24 January 2020

How Qasem Soleimani was Assassinated with MQ-9 REAPER Military Drone


1,234,158 views
Jan 9, 2020
Qasem Soleimani was an Iranian Military General who led a special guerrilla unit known as the Quds forces, He was one of the most powerful and feared military leaders in the whole of the middle east and Iran specifically. Due to his position, he had many enemies around the world and in the west specifically, Soleimani had survived several assassination attempts by Western, Israeli and Arab agencies over the past two decades. Previous US presidents before Donald Trump had tried to assassinate him but they feared that the consequences will be too big, so some tried to do it covertly, Last year Tehran said it foiled an assassination attempt by Israeli and Arab spies, who tried to buy a property next to a mosque built by Soleimani’s father in the city of Kerman so they could dig a tunnel and plant explosives to blow him up during a religious ceremony. For years, the U.S. military kept close tabs on the Iranian General Every day. Whom he met. What he planned.... The MQ-9 Reaper is one of the deadliest military drones in the world, it is an expensive piece of military hardware at $64 million, the MQ-9 is an unmanned aerial vehicle that came into service in 2007 retiring the previously used MQ-1 predator A. It is currently operated by Australia, France, America, Belgium, United Kingdom, India and a few other powerful nations. The Reaper is a remotely piloted weapons platform capable of instant action and engagement. It is equipped with some of the best military tech out there, The baseline system carries the Multi-Spectral Targeting System, which has a robust suite of visual sensors for targeting, The MTS-B integrates an infrared sensor, color/monochrome daylight TV camera, image-intensified TV camera, laser designator, and laser illuminator. Social Media: Instagram: https://www.instagram.com/tech_overwa... Twitter: https://twitter.com/Tech_OverWatch Facebook: https://www.facebook.com/Wetechsavvy/

No comments:

No comment